Tobam Novavax Inc Transaction History

Tobam

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$36.28 - $75.29 $6.3 Million - $13.1 Million	-173,685 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$69.73 - $142.9 $5.51 Million - $11.3 Million	78,970 Added 83.38%	173,685 $12.8 Million
Q4 2021 Feb 15, 2022	BUY	$134.56 - $217.97 $926,849 - $1.5 Million	6,888 Added 7.84%	94,715 $13.6 Million
Q3 2021 Nov 12, 2021	SELL	$177.8 - $270.58 $3.4 Million - $5.17 Million	-19,120 Reduced 17.88%	87,827 $18.2 Million
Q2 2021 Aug 11, 2021	BUY	$121.0 - $257.67 $12.2 Million - $25.9 Million	100,574 Added 1578.13%	106,947 $22.7 Million
Q1 2021 May 11, 2021	BUY	$112.98 - $319.93 $720,021 - $2.04 Million	6,373 New	6,373 $1.16 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

Stay updated on Tobam with notifications on news.